Atmospheric pressure gas plasma-induced colorectal cancer cell death is mediated by Nox2-ASK1 apoptosis pathways and oxidative stress is mitigated by Srx-Nrf2 anti-oxidant system

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 12, 2014, Pages 2827-2837

  Ishaq, Musarat ^a   Evans, Margaret D M ^a   Ostrikov, Kostya Ken ^a,b  

^a CSIRO   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Apoptosis; Apoptosis signal regulating kinase 1 (ASK1); Atmospheric pressure gas plasmas (AGP); NADPH oxidase (Nox); Nuclear factor erythroid 2 related factor 2 (Nrf2); Reactive oxygen species (ROS); Sulfiredoxin (Srx)

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; APOPTOSIS SIGNAL REGULATING KINASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA; SULFIREDOXIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATMOSPHERIC PRESSURE GAS PLASMA; CACO 2 CELL LINE; CANCER RESISTANCE; CANCER THERAPY; CELL VIABILITY; CHEMOSENSITIZATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; GASES, FUMES, VAPORS AND RELATED PHENOMENA; GENE SILENCING; HT 29 CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLASMA GAS; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84907462371     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.08.011     Document Type: Article

References (53)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64:9-29.
2. Ishaq M., Evans M.M., Ostrikov K. Effect of atmospheric gas plasmas on cancer cell signalling. Int. J. Cancer 2014, 134:1517-1528.
3. Graves D.B. The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology. J. Phys. D. Appl. Phys. 2012, 45:263001-263042.
4. Keidar M., Walk R., Shashurin A., Srinivasan P., Sandler A., Dasgupta S., Ravi R., Guerrero-Preston R., Trink B. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br. J. Cancer 2011, 105:1295-1301.
5. Kim J.Y., Wei Y., Li J., Foy P., Hawkins T., Ballato J., Kim S.-O. Single-cell-level microplasma cancer therapy. Small 2011, 7:2291-2295.
6. Vandamme M., Robert E., Lerondel S., Sarron V., Ries D., Dozias S., Sobilo J., Gosset D., Kieda C., Legrain B., Pouvesle J.M., Le Pape A. ROS implication in a new antitumor strategy based on non-thermal plasma. Int. J. Cancer 2012, 130:2185-2194.
7. Volotskova O., Hawley T.S., Stepp M.A., Keidar M. Targeting the cancer cell cycle by cold atmospheric plasma. Sci. Rep.-Uk 2012, 2. (636-610).
8. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
9. Ishaq M., Kumar S., Varinli H., Han Z., Rider A.E., Evans M.D., Murphy A.B., Ostrikov K. Atmospheric gas plasma-induced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosis. Mol. Biol. Cell 2014, 25:1523-1531.
10. Ichijo H., Nishida E., Irie K., tenDijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90-94.
11. Liu H., Nishitoh H., Ichijo H., Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell. Biol. 2000, 20:2198-2208.
12. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 1998, 2:389-395.
13. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001, 2:222-228.
14. Brar S.S., Kennedy T.P., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Whorton A.R., Hoidal J.R. An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am. J. Physiol. Cell Physiol. 2002, 282:C1212-C1224.
15. Geiszt M. NADPH oxidases: new kids on the block. Cardiovasc. Res. 2006, 71:289-299.
16. Terada L.S. Specificity in reactive oxidant signaling: think globally, act locally. J. Cell Biol. 2006, 174:615-623.
17. Van Laethem A., Nys K., Van Kelst S., Claerhout S., Ichijo H., Vandenheede J.R., Garmyn M., Agostinis P. Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Free Radic. Biol. Med. 2006, 41:1361-1371.
18. Chiang E., Dang O., Anderson K., Matsuzawa A., Ichijo H., David M. Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide. J. Immunol. 2006, 176:5720-5724.
19. Kensler T.W., Wakabayashi N. Nrf2: friend or foe for chemoprevention?. Carcinogenesis 2010, 31:90-99.
20. Wei Q., Jiang H., Xiao Z., Baker A., Young M.R., Veenstra T.D., Colburn N.H. Sulfiredoxin-peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7004-7009.
21. Singh A., Ling G.Y., Suhasini A.N., Zhang P., Yamamoto M., Navas-Acien A., Cosgrove G., Tuder R.M., Kensler T.W., Watson W.H., Biswal S. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic. Biol. Med. 2009, 46:376-386.
22. Wei Q., Jiang H., Matthews C.P., Colburn N.H. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19738-19743.
23. Woo H.A., Jeong W., Chang T.S., Park K.J., Park S.J., Yang J.S., Rhee S.G. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J. Biol. Chem. 2005, 280:3125-3128.
24. Soriano F.X., Baxter P., Murray L.M., Sporn M.B., Gillingwater T.H., Hardingham G.E. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol. Cells 2009, 27:279-282.
25. Lua X.P., Naidis G.V., Laroussi M., Ostrikov K. Guided ionization waves: theory and experiments. Phys. Rep. 2014, 540:123-166.
26. Ishaq M., Hu J., Wu X., Fu Q., Yang Y., Liu Q., Guo D. Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis. Mol. Biotechnol. 2008, 39:231-238.
27. Ishaq M., Ma L., Wu X., Mu Y., Pan J., Hu J., Hu T., Fu Q., Guo D. The DEAD-box RNA helicase DDX1 interacts with RelA and enhances nuclear factor kappaB-mediated transcription. J. Cell. Biochem. 2009, 106:296-305.
28. Noguchi T., Ishii K., Fukutomi H., Naguro I., Matsuzawa A., Takeda K., Ichijo H. Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 2008, 283:7657-7665.
29. Wang H., Kochevar I.E. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic. Biol. Med. 2005, 38:890-897.
30. Jiang F., Zhang Y., Dusting G.J. NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol. Rev. 2011, 63:218-242.
31. Homma S., Ishii Y., Morishima Y., Yamadori T., Matsuno Y., Haraguchi N., Kikuchi N., Satoh H., Sakamoto T., Hizawa N., Itoh K., Yamamoto M. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 2009, 15:3423-3432.
32. Kalghatgi S., Kelly C.M., Cerchar E., Torabi B., Alekseev O., Fridman A., Friedman G., Azizkhan-Clifford J. Effects of non-thermal plasma on mammalian cells. Plos One 2011, 6:e16270.
33. Sensenig R., Kalghatgi S., Cerchar E., Fridman G., Shereshevsky A., Torabi B., Arjunan K.P., Podolsky E., Fridman A., Friedman G., Azizkhan-Clifford J., Brooks A.D. Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann. Biomed. Eng. 2011, 39:674-687.
34. Yan X., Xiong Z., Zou F., Zhao S., Lu X., Yang G., He G., Ostrikov K. Plasma-induced death of HepG2 cancer cells: intracellular effects of reactive species. Plasma Process. Polym. 2012, 9:59-66.
35. Maher J.M., Dieter M.Z., Aleksunes L.M., Slitt A.L., Guo G., Tanaka Y., Scheffer G.L., Chan J.Y., Manautou J.E., Chen Y., Dalton T.P., Yamamoto M., Klaassen C.D. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007, 46:1597-1610.
36. Wei Q., Jiang H., Baker A., Dodge L.K., Gerard M., Young M.R., Toledano M.B., Colburn N.H. Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. Carcinogenesis 2013, 34:1403-1410.
37. Noh Y.H., Baek J.Y., Jeong W., Rhee S.G., Chang T.S. Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J. Biol. Chem. 2009, 284:8470-8477.
38. 2 signaling pathways. Methods Enzymol. 2013, 527:113-128.
39. Bae S.H., Woo H.A., Sung S.H., Lee H.E., Lee S.K., Kil I.S., Rhee S.G. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid. Redox Signal. 2009, 11:937-948.
40. Soriano F.X., Leveille F., Papadia S., Higgins L.G., Varley J., Baxter P., Hayes J.D., Hardingham G.E. Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J. Neurochem. 2008, 107:533-543.
41. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
42. Furukawa M., Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 2005, 25:162-171.
43. Shibata T., Ohta T., Tong K.I., Kokubu A., Odogawa R., Tsuta K., Asamura H., Yamamoto M., Hirohashi S. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13568-13573.
44. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008, 135:1358-1368.
45. Nioi P., Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 2007, 362:816-821.
46. Zhang P., Singh A., Yegnasubramanian S., Esopi D., Kombairaju P., Bodas M., Wu H., Bova S.G., Biswal S. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 2010, 9:336-346.
47. Muscarella L.A., Barbano R., D'Angelo V., Copetti M., Coco M., Balsamo T., la Torre A., Notarangelo A., Troiano M., Parisi S., Icolaro N., Catapano D., Valori V.M., Pellegrini F., Merla G., Carella M., Fazio V.M., Parrella P. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics 2011, 6:317-325.
48. Tong W.G., Ding X.Z., Talamonti M.S., Bell R.H., Adrian T.E. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem. Biophys. Res. Commun. 2005, 335:949-956.
49. Yoo M.H., Song H.W., Woo C.H., Kim H.G., Kim J.H. Role of the BLT2, a leukotriene B-4 receptor, in Ras transformation. Oncogene 2004, 23:9259-9268.
50. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.M., Cavenee W.K., DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Gene Dev. 2001, 15:1311-1333.
51. Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., Oconnor P.M., Anderson C.W., Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 1995, 270:29386-29391.
52. Cariou S., Donovan J.C.H., Flanagan W.M., Milic A., Bhattacharya N., Slingerland J.M. Down-regulation of p21(WAF1/CIP1) or p27(Kip1) abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9042-9046.
53. Ralat L.A., Manevich Y., Fisher A.B., Colman R.F. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry 2006, 45:360-372.